BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26740152)

  • 1. N-(3,4-Dimethylisoxazol-5-yl)piperazine-4-[4-(2-fluoro-4-[(11)C]methylphenyl)thiazol-2-yl]-1-carboxamide: A promising positron emission tomography ligand for fatty acid amide hydrolase.
    Shimoda Y; Fujinaga M; Hatori A; Yui J; Zhang Y; Nengaki N; Kurihara Y; Yamasaki T; Xie L; Kumata K; Ishii H; Zhang MR
    Bioorg Med Chem; 2016 Feb; 24(4):627-34. PubMed ID: 26740152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of [(11)C]MFTC for PET imaging of fatty acid amide hydrolase in rat and monkey brains.
    Kumata K; Yui J; Hatori A; Maeda J; Xie L; Ogawa M; Yamasaki T; Nagai Y; Shimoda Y; Fujinaga M; Kawamura K; Zhang MR
    ACS Chem Neurosci; 2015 Feb; 6(2):339-46. PubMed ID: 25398123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an In Vivo Method to Estimate Effective Drug Doses and Quantify Fatty Acid Amide Hydrolase in Rodent Brain using Positron Emission Tomography Tracer [
    Yamasaki T; Ohya T; Mori W; Zhang Y; Wakizaka H; Nengaki N; Fujinaga M; Kikuchi T; Zhang MR
    J Pharmacol Exp Ther; 2020 Jun; 373(3):353-360. PubMed ID: 32241809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography.
    Wilson AA; Garcia A; Parkes J; Houle S; Tong J; Vasdev N
    Nucl Med Biol; 2011 Feb; 38(2):247-53. PubMed ID: 21315280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging of fatty acid amide hydrolase in the brain: synthesis and biological evaluation of an 11C-labelled URB597 analogue.
    Wyffels L; Muccioli GG; Kapanda CN; Labar G; De Bruyne S; De Vos F; Lambert DM
    Nucl Med Biol; 2010 Jul; 37(5):665-75. PubMed ID: 20610171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Preliminary PET Imaging Studies of a FAAH Radiotracer ([¹¹C]MPPO) Based on α-Ketoheterocyclic Scaffold.
    Wang L; Yui J; Wang Q; Zhang Y; Mori W; Shimoda Y; Fujinaga M; Kumata K; Yamasaki T; Hatori A; Rotstein BH; Collier TL; Ran C; Vasdev N; Zhang MR; Liang SH
    ACS Chem Neurosci; 2016 Jan; 7(1):109-18. PubMed ID: 26505525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase.
    Hicks JW; Parkes J; Sadovski O; Tong J; Houle S; Vasdev N; Wilson AA
    Nucl Med Biol; 2013 Aug; 40(6):740-6. PubMed ID: 23731552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and preliminary evaluation of a novel positron emission tomography (PET) ligand for imaging fatty acid amide hydrolase (FAAH).
    Chen Z; Hou L; Gan J; Cai Q; Ye W; Chen J; Tan Z; Zheng C; Li G; Xu H; Fowler CJ; Liang SH; Wang L
    Bioorg Med Chem Lett; 2020 Nov; 30(21):127513. PubMed ID: 32860981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methyl-4-[11C]methylbenzamide for positron emission tomography imaging of metabotropic glutamate 1 receptor in monkey brain.
    Fujinaga M; Yamasaki T; Maeda J; Yui J; Xie L; Nagai Y; Nengaki N; Hatori A; Kumata K; Kawamura K; Zhang MR
    J Med Chem; 2012 Dec; 55(24):11042-51. PubMed ID: 23194448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of a promising fluorine-18 labelled radiopharmaceutical for in vivo imaging of fatty acid amide hydrolase.
    Sadovski O; Hicks JW; Parkes J; Raymond R; Nobrega J; Houle S; Cipriano M; Fowler CJ; Vasdev N; Wilson AA
    Bioorg Med Chem; 2013 Jul; 21(14):4351-7. PubMed ID: 23712084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosynthesis and evaluation of [¹¹C-carbonyl]-labeled carbamates as fatty acid amide hydrolase radiotracers for positron emission tomography.
    Wilson AA; Hicks JW; Sadovski O; Parkes J; Tong J; Houle S; Fowler CJ; Vasdev N
    J Med Chem; 2013 Jan; 56(1):201-9. PubMed ID: 23214511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosynthesis and preliminary evaluation of 4-[18F]fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methylbenzamide as a new positron emission tomography ligand for metabotropic glutamate receptor subtype 1.
    Yamasaki T; Fujinaga M; Yoshida Y; Kumata K; Yui J; Kawamura K; Hatori A; Fukumura T; Zhang MR
    Bioorg Med Chem Lett; 2011 May; 21(10):2998-3001. PubMed ID: 21470858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester.
    Gao M; Mock BH; Hutchins GD; Zheng QH
    Nucl Med Biol; 2005 Jul; 32(5):543-52. PubMed ID: 15982585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain.
    Fujinaga M; Yamasaki T; Yui J; Hatori A; Xie L; Kawamura K; Asagawa C; Kumata K; Yoshida Y; Ogawa M; Nengaki N; Fukumura T; Zhang MR
    J Med Chem; 2012 Mar; 55(5):2342-52. PubMed ID: 22316010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fatty-acid amide hydrolase inhibitor URB597 does not affect triacylglycerol hydrolysis in rat tissues.
    Clapper JR; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
    Pharmacol Res; 2006 Nov; 54(5):341-4. PubMed ID: 16935521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of 1-[2-(4-[(11)C]methoxyphenyl)phenyl]piperazine for imaging of the serotonin 5-HT7 receptor in the rat brain.
    Shimoda Y; Yui J; Xie L; Fujinaga M; Yamasaki T; Ogawa M; Nengaki N; Kumata K; Hatori A; Kawamura K; Zhang MR
    Bioorg Med Chem; 2013 Sep; 21(17):5316-22. PubMed ID: 23830697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH).
    Skaddan MB; Zhang L; Johnson DS; Zhu A; Zasadny KR; Coelho RV; Kuszpit K; Currier G; Fan KH; Beck EM; Chen L; Drozda SE; Balan G; Niphakis M; Cravatt BF; Ahn K; Bocan T; Villalobos A
    Nucl Med Biol; 2012 Oct; 39(7):1058-67. PubMed ID: 22571907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging of fatty acid amide hydrolase with [(18)F]DOPP in nonhuman primates.
    Rotstein BH; Wey HY; Shoup TM; Wilson AA; Liang SH; Hooker JM; Vasdev N
    Mol Pharm; 2014 Nov; 11(11):3832-8. PubMed ID: 25004399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [carbonyl-11C]4-Fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([11C]FIMX) is an effective radioligand for PET imaging of metabotropic glutamate receptor 1 (mGluR1) in monkey brain.
    Hong J; Lu S; Xu R; Liow JS; Woock AE; Jenko KJ; Gladding RL; Zoghbi SS; Innis RB; Pike VW
    Nucl Med Biol; 2015 Dec; 42(12):967-74. PubMed ID: 26320813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and preclinical evaluation of [¹⁸F]FCHC for neuroimaging of fatty acid amide hydrolase.
    Shoup TM; Bonab AA; Wilson AA; Vasdev N
    Mol Imaging Biol; 2015 Apr; 17(2):257-63. PubMed ID: 25273322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.